Crystal structure of actinomycin D bound to the CTG triplet repeat sequences linked to neurological diseases

The potent anticancer drug actinomycin D (ActD) acts by binding to DNA GpC sequences, thereby interfering with essential biological processes including replication, transcription and topoisomerase. Certain neurological diseases are correlated with expansion of (CTG)(n) trinucleotide sequences, which...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	Nucleic Acids Res
Egile Nagusiak:	Hou, Ming-Hon, Robinson, Howard, Gao, Yi-Gui, Wang, Andrew H.-J.
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Oxford University Press 2002
Gaiak:	Articles
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC137167/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12433994/ https://ncbi.nlm.nih.govhttps://doi.org/10.1093/nar/gkf619
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!